Singapore, Aug. 24 -- South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies, has announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California, US.

Published by HT Digital Content Services with permission from BioSpectrum Asia....